- Pulsed Field Ablation Versus Sham to Treat Atrial Fibrillation: The PFA-SHAM Randomized Clinical Trial
- Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways
- Response by Croon and Khera to Letter Regarding Article, “Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction”
- Letter by Liu and Yao Regarding Article, “Phenotypic Selectivity of Artificial Intelligence–Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction”
- Anticoagulation Services as a Model for Cardiovascular Medication Stewardship
- Highlights From the Circulation Family of Journals
- Ultra-Processed Foods Harm Male Metabolic and Reproductive Health
- Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension
- Correction to: Abstract 4368321: A Rare Unusual Location Of A Papillary Fibroelastoma Originating From The Coumadin Ridge
- Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial
- Lipoprotein (a) in High-Risk Primary Prevention: Making the Best of What We Have
- Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial
- SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure
- Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation
